Delivery Order SPE2DB20D1100-SPE2DB24FD2N2

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,757.05, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a Delivery Order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to $999,999,999.00 and provides a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,521.00 Firm Fixed Price Delivery Order is for the supply of 36,000 unit capsules of a pharmaceutical product called "CREON DR 36,000 UNIT CAPSULE 100S". The award has an ultimate completion date of September 23, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $27,526.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award, valued at $1,711.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB25FT7Q8) with a firm fixed price and an ultimate completion date of January 9, 2025. The award covers the delivery of 24,000 units of the product "CREON DR 24,000 UNIT CAPSULE UU 100S" and does not have a set-aside designation. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,540.12 firm fixed-price delivery order is for the supply of 36,000 unit capsules of the pharmaceutical product CREON DR. The award is not a set-aside and has an ultimate completion date of August 5, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with significant Indefinite...
This federal contract award, valued at $1,077.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award, with a ceiling value of $3,889.25, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for the supply of 12,000 unit capsules of the drug CREON DR, a treatment for pancreatic enzyme deficiency. This award does not utilize any set-aside designations. Amerisourcebergen has been awarded numerous federal contracts by the DLA and other agencies, leveraging...
This federal contract award, valued at $1,685.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the provision of 24,000 unit capsules of the product "CREON DR". The contract has an ultimate completion date of February 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,445.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract involves the delivery of 36,000 units of the pharmaceutical product CREON DR 36,000 UNIT CAPSULE UU 100S. The award is a Firm Fixed Price Delivery Order with a completion date of September 20, 2024. This contract award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
This federal contract award, valued at $3,659.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB24FP94C) against an Indefinite Delivery Contract (SPE2DB20D1109) held by Amerisourcebergen with the DLA Troop Support Medical. The contract covers the delivery of 24,000 unit capsules of the pharmaceutical product "CREON DR 24,000 UNIT CAPSULE UU...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD2N2
    Delivery Order

This federal contract award, worth $1,386.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The award is a delivery order for 6,000 unit capsules of the pharmaceutical product CREON DR. As a major supplier of pharmaceutical and medical products to the U.S. government, Amerisourcebergen has been awarded numerous federal contracts, including a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical for providing a comprehensive range of medical commodities. This current award is not set aside and is a firm fixed-price contract with an ultimate completion date of August 14, 2024.

Generated 11/12/24, 9:15 AM